...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Early Warning Report

Wondering if there will be any major  Zenith business developements, ie a partnership/co development deal announced prior to the AGM,  IMO, if a major deal is announced (that is a big if) that will have a net benefit increase in share price with RVX with the opinion of a pending partnership deal coming shortly. ALL IMO.

Share
New Message
Please login to post a reply